冠状病毒疫苗研究进展

被引：7

作者：

马艺文 ^{[1
]}

付雅璐 ^{[1
]}

肖鑫 ^{[2
]}

王微 ^{[3
]}

机构：

[1] 空军军医大学基础医学院二大队

[2] 空军军医大学第一附属医院骨科

[3] 空军军医大学基础医学院免疫学教研室

来源：

传染病信息 | 2020年 / 01期

关键词：

疫苗; 严重急性呼吸综合征冠状病毒; 中东呼吸综合征冠状病毒; 严重急性呼吸综合征冠状病毒-2;

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100108 [医学免疫学];

摘要：

进入21世纪以来,严重急性呼吸综合征冠状病毒(severe acute respiratory syndrome coronavirus, SARS-CoV)、中东呼吸综合征冠状病毒(Middle East respiratory syndromecoronavirus, MERS-CoV)及最新出现的严重急性呼吸综合征冠状病毒-2(severe acute respiratory syndrome coronavirus-2, SARS-CoV-2)等高致病性冠状病毒先后在人群中暴发流行,成为影响地区、国家乃至全球的重大公共卫生事件,研发特异性疫苗成为防控病毒流行的当务之急。本文综述了SARS-CoV和MERS-CoV疫苗的研究进展,望对SARS-CoV-2疫苗研制提供参考。

引用

页码：65 / 70

页数：6

共 20 条

[1]

WHO对年度优先关注突发传染病的评估方法介绍 [J].

许庭莹 ;

石大伟 ;

刘东来 ;

张春涛 .

传染病信息, 2019, 32 (05) :385-389

[2]

中东呼吸综合征冠状病毒重组疫苗研究进展[J] 胡慧祯;沈宇清; 病毒学报 2016, 04

[3]

Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus[J] Seo-Yeon Jung;Kyung Won Kang;Eun-Young Lee;Dong-Won Seo;Hong-Lim Kim;Hak Kim;TaeWoo Kwon;Hye-Lim Park;Hun Kim;Sang-Myeong Lee;Jae-Hwan Nam Vaccine 2018,

[4]

DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice[J] Hang Chi;Xuexing Zheng;Xiwen Wang;Chong Wang;Hualei Wang;Weiwei Gai;Stanley Perlman;Songtao Yang;Jincun Zhao;Xianzhu Xia Vaccine 2017,

[5]

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates[J] Karuppiah Muthumani;Darryl Falzarano;Emma L. Reuschel;Colleen Tingey;Seleeke Flingai;Daniel O. Villarreal;Megan Wise;Ami Patel;Abdullah Izmirly;Abdulelah Aljuaid;Alecia M. Seliga;Geoff Soule;Matthew Morrow;Kimberly A. Kraynyak;Amir S. Khan;Dana P. Scott;Friederike Feldmann;Rachel LaCasse;Kimberly Meade-White;Atsushi Okumura;Kenneth E. Ugen;

[6]

Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design[J] Cuiqing Ma;Lili Wang;Xinrong Tao;Naru Zhang;Yang Yang;Chien-Te K Tseng;Fang Li;Yusen Zhou;Shibo Jiang;Lanying Du Vaccine 2014,

[7]

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice[J] Eun Kim;Kaori Okada;Tom Kenniston;V. Stalin Raj;Mohd M. AlHajri;Elmoubasher A.B.A. Farag;Farhoud AlHajri;Albert D.M.E. Osterhaus;Bart L. Haagmans;Andrea Gambotto Vaccine 2014,

[8]

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines[J] Cuiqing Ma;Ye Li;Lili Wang;Guangyu Zhao;Xinrong Tao;Chien-Te K. Tseng;Yusen Zhou;Lanying Du;Shibo Jiang Vaccine 2014,

[9]

Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies[J] Fei Song;Robert Fux;Lisette B. Provacia;Asisa Volz;Markus Eickmann;Stephan Becker;Albert D. M. E. Osterhaus;Bart L. Haagmans;Gerd Sutter Journal of Virology 2013,

[10]

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development[J] Lanying Du;Guangyu Zhao;Zhihua Kou;Cuiqing Ma;Shihui Sun;Vincent K. M. Poon;Lu Lu;Lili Wang;Asim K. Debnath;Bo-Jian Zheng;Yusen Zhou;Shibo Jiang Journal of Virology 2013,

← 1 2 →